AWM
HURA

Apollon Wealth Management’s TuHURA Biosciences HURA Stock Holding History

Apollon Wealth Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Sell
156,519
-1,491
-0.9% -$3.47K ﹤0.01% 1162
2026
Q1 		$283K Buy
158,010
+23,717
+18% +$29.1K ﹤0.01% 1151
2025
Q4 		$102K Buy
134,293
+767
+0.6% +$1.47K ﹤0.01% 1262
2025
Q3 		$331K Buy
133,526
+18,252
+16% +$48K 0.01% 1014
2025
Q2 		$257K Buy
115,274
+348
+0.3% +$1.18K 0.01% 1073
2025
Q1 		$371K Buy
114,926
+53,154
+86% +$196K 0.01% 869
2024
Q4 		$253K Buy
+61,772
New +$328K 0.01% 1007

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Apollon Wealth Management's HURA Position: Q2 2026 in Review

Apollon Wealth Management reduced its TuHURA Biosciences (HURA) stake by 0.94% in Q2 2026, selling an estimated $3.47K and leaving 156,519 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #1162.

Apollon Wealth Management first reported a position in HURA in Q4 2024 and has held it in 7 quarters since. The position peaked at $371K in Q1 2025. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Apollon Wealth Management held 156,519 shares of TuHURA Biosciences worth $366K as of Q2 2026.
  • Apollon Wealth Management sold 1,491 TuHURA Biosciences shares in Q2 2026, an estimated $3.47K.
  • TuHURA Biosciences made up ﹤0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #1162 holding.
  • Apollon Wealth Management first reported a position in TuHURA Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Apollon Wealth Management's TuHURA Biosciences position peaked at $371K in Q1 2025.
  • 90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.